| Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study) |
41 |
| Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naive men with suspicion of prostate cancer |
29 |
| National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting |
27 |
| A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol |
26 |
| Risk of metastatic disease on (68)gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer |
25 |
| Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review |
25 |
| Impact of bladder cancer on health-related quality of life |
22 |
| Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer |
21 |
| Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis |
20 |
| Diagnostic accuracy of Ga-68-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of Ga-68-PSMA PET to mpMRI |
19 |
| Single-port robot-assisted laparoscopic radical prostatectomy: initial experience and technique with the da Vinci (R) SP platform |
19 |
| TheraP: a randomized phase 2 trial of Lu-177-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603) |
18 |
| Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm |
17 |
| The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis |
17 |
| Gallium-68-prostate-specific membrane antigen (Ga-68-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer |
17 |
| Guideline of guidelines: bladder pain syndrome |
17 |
| The United States opioid epidemic: a review of the surgeon's contribution to it and health policy initiatives |
17 |
| Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis |
17 |
| European experience of robot-assisted kidney transplantation: minimum of 1-year follow-up |
16 |
| Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration |
16 |
| Augmented-reality robot-assisted radical prostatectomy using hyper-accuracy three-dimensional reconstruction (HA3D (TM)) technology: a radiological and pathological study |
16 |
| Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer |
16 |
| Defining a glycated haemoglobin (HbA1c) level that predicts increased risk of penile implant infection |
16 |
| Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer |
16 |
| Current status of artificial intelligence applications in urology and their potential to influence clinical practice |
16 |
| Intracorporeal robot-assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains |
15 |
| Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer |
15 |
| Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naive patients: a diagnostic test accuracy systematic review and meta-analysis |
15 |
| Guideline of guidelines: asymptomatic microscopic haematuria |
14 |
| Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance |
14 |
| A deep-learning model using automated performance metrics and clinical features to predict urinary continence recovery after robot-assisted radical prostatectomy |
14 |
| A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both procedures |
14 |
| Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients |
14 |
| Resident burnout in USA and European urology residents: an international concern |
14 |
| Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study |
14 |
| First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study |
13 |
| A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens |
13 |
| Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study |
13 |
| Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trial |
13 |
| Outcomes of inflatable penile prosthesis insertion in 247 patients completing female to male gender reassignment surgery |
13 |
| First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune (R) |
13 |
| Single-use disposable digital flexible ureteroscopes: an ex vivo assessment and cost analysis |
13 |
| 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction |
13 |
| Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate |
12 |
| Ex vivo fluorescence confocal microscopy: the first application for real-time pathological examination of prostatic tissue |
12 |
| Vaccines for the prevention of recurrent urinary tract infections: a systematic review |
12 |
| Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer |
12 |
| The neurovascular structure-adjacent frozen-section examination (NeuroSAFE) approach to nerve sparing in robot-assisted laparoscopic radical prostatectomy in a British setting - a prospective observational comparative study |
12 |
| Associations of specific postoperative complications with costs after radical cystectomy |
12 |
| Four-year outcomes from a multiparametric magnetic resonance imaging (MRI)-based active surveillance programme: PSA dynamics and serial MRI scans allow omission of protocol biopsies |
12 |
